CMA
53
3
MCD
54
4
BRK.B
27
2
ORCL
58
4
M
30
2
USB
46
3
TGNA
37
-3
IPG
50
2
PCG
77
3
AVY
53
3
TDC
47
-39
BK
69
4
LOW
53
3
AMAT
46
6
AVB
54
9
VZ
37
3
JPM
59
3
ESS
56
5
RSG
62
2
KMI
69
4
CMA
53
3
MCD
54
4
BRK.B
27
2
ORCL
58
4
M
30
2
USB
46
3
TGNA
37
-3
IPG
50
2
PCG
77
3
AVY
53
3
TDC
47
-39
BK
69
4
LOW
53
3
AMAT
46
6
AVB
54
9
VZ
37
3
JPM
59
3
ESS
56
5
RSG
62
2
KMI
69
4
Financhill
Back

US Physical Therapy 10K Form

Sell
45

USPH
US Physical Therapy

Last Price:
97.02
Seasonality Move:
8.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive USPH News And Ratings

See the #1 stock for the next 7 days that we like better than USPH

USPH Financial Statistics

Sales & Book Value

Annual Sales: $604.8M
Cash Flow: $26.66M
Price / Cash Flow: 18.32
Annual Sales: $32.14
Price / Book: 2.57

Profitability

EPS (TTM): 1.82000
Net Income (TTM): $12.58M
Gross Margin: $121.51M
Return on Equity: 1.9%
Return on Assets: 1.25%

US Physical Therapy Earnings Forecast

Key US Physical Therapy Financial Ratios

  • The Gross Profit Margin over the past 33 years for USPH is 20.09%.
  • The Selling, General & Administrative Expenses for USPH have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 63.40% of Operating Income.
  • The Net Earning history of USPH is 2.43% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 17 years.

US Physical Therapy Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: USPH
CUSIP: 90337L
Website: usph.com

Debt

Debt-to-Equity Ratio: 0.3
Current Ratio: 1.88
Quick Ratio: 1.77

Price-to-Earnings

Trailing P/E Ratio: 64.48
Forward P/E Ratio: 28.21

USPH Technical Analysis vs Fundamental Analysis

Sell
45
US Physical Therapy (USPH) is a Sell

Is US Physical Therapy a Buy or a Sell?